Stocks and Investing
Stocks and Investing
Wed, May 16, 2018
Tue, May 15, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 14, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 11, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Nierengarten Upgraded (VYGR) to Buy on, May 11th, 2018
David Nierengarten of Wedbush, Upgraded "Voyager Therapeutics, Inc." (VYGR) to Buy on, May 11th, 2018.
David has made no other calls on VYGR in the last 4 months.
There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, March 12th, 2018
These are the ratings of the 2 analyists that currently disagree with David
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Thursday, March 15th, 2018
- Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Wednesday, February 21st, 2018